Seoul, South Korea – February 5, 2026 – The recent implementation of South Korea’s ‘Post-Notification System’ for pharmaceutical substitutions is facing strong backlash from the medical community, especially from internal medicine physicians. Critics argue the policy, which went into full effect this month, compromises patient safety and represents a hasty decision.
What is the Post-Notification System?
The Post-Notification System requires physicians to inform patients after a pharmacist has substituted a prescribed medication with an alternative. This differs from prior practices where physician consent was generally required before a substitution occurred. The stated goal of the system, according to the Ministry of Health and Welfare, is to streamline medication access and reduce potential delays in treatment Korea Herald.
Physician Concerns Regarding Patient Safety
Internal medicine doctors express important concerns that the post-notification approach undermines the physician-patient relationship and possibly endangers patients. Key criticisms include:
- Lack of Physician Oversight: The system reduces the physician’s ability to make informed decisions about the most appropriate medication for a patient’s specific condition, leading to suboptimal treatment plans.
- Potential for Adverse Reactions: Pharmacists may not have a complete understanding of a patient’s medical history or potential drug interactions, increasing the risk of adverse reactions.
- Erosion of Trust: Physicians believe the system erodes patient trust when they are not involved in decisions regarding their medication.
- Administrative burden: While intended to simplify processes, many physicians anticipate increased administrative burden associated with addressing patient concerns and potential complications arising from substitutions.
Government Rationale and Supporting Arguments
The Ministry of Health and welfare defends the system, claiming it addresses issues of medication availability and cost. Supporters argue:
- Increased Access to Medication: the system can help ensure patients receive necessary medications even if the originally prescribed brand is unavailable.
- Cost Reduction: Substituting with generic or biosimilar medications can lower healthcare costs for both patients and the national health insurance system.
- Pharmacist Expertise: The government emphasizes the clinical expertise of pharmacists and their ability to make safe and appropriate substitutions.
impact on Specific Patient Populations
Concerns are particularly acute for patients with complex medical conditions or those taking multiple medications. the potential for drug interactions and the importance of continuity of care are paramount in these cases. Medical organizations are advocating for exceptions to the rule for these vulnerable groups.
The Role of Generic Medications
The debate also highlights broader discussions about the use of generic medications. While generally considered safe and effective, concerns remain about bioequivalence and the potential for varying clinical outcomes FDA – Generic Drugs. Physicians emphasize the need for robust quality control measures and ongoing monitoring to ensure patient safety when using generic alternatives.
Future Outlook and Potential Revisions
The Korean medical community is actively lobbying for a revision of the Post-notification System.Possible solutions being discussed include requiring physician consent for all substitutions, particularly for patients with complex conditions, and strengthening communication between physicians and pharmacists. It remains to be seen whether the government will consider these changes. The situation warrants close monitoring as its impact on patient care unfolds.